2Pannek J, St/.;hrer M, Blok B, et al. EAU guidelines on neuro- genie lower urinary tract dysfunction [ EB/OL]. [ 2015-02-02]. www. uroweb.org/gls/pdf/17_Neurogenic% 20LUTS.pdf.
3Abrams P, Cardozo L, Fall M, et al. The standardization of ter- minq!ogy of lower urinary tract function [ J]. Neurourol Urodyn, 2002, 21: 167-178.
4Liao LM. A new comprehensive classification system for both low- er and upper urinary tract dysfunction in patients with neurogenic bladder [J/OLI. Urol Int, 2014 Aug 8 [2015-02-02]. http:// www. karger, corn/Article/Abstract/365056. [ published online ahead of print August 8, 2014].
5Liao LM, Zhang F, Chen GQ. New grading system tor upper uri- nary tract dilation using magnetic resonance urography in patients with neurogenic bladder [J]. BMC Urol, 2014, 14: 38-45.
6Burks FN, Bui DT, Peters KM. Neuromodulation and the neuro- genic bladder [J]. Urol Clin North Am, 2010, 37: 559-565.
10Possover M. A novel implantation technique for pudendal nerve stimulation for treatment of overactive bladder and urgency incon- tinence [J]. J Minim Invasive Gynecol, 2014, 21: 888-892.
2[1]Lavelle JP, Teahan S, Kim DY et al. Medical and minimally invasive treatment of incontinence. Rev Urol, 1999, 1: 111
3[2]De Groat WC. Neuroanatomy and neurophysiology: innervation of the lower urinary tract. In: Raz S ed. Female Urology. Philadelphia: WB Saunders, 1996.28
4[3]Goodwin RJ, Swinn MJ, Fowler CJ. The neurophysiology of urinary retention in young women and its treatment by neuromodulation. World J Urol, 1998, 16: 305
5[4]Thon W, Baskin L, Jonas U et al. Neuromodulation of voiding dysfunction and pelvic pain. World J Urol, 1991, 9: 138
6[5]Shaker HS, Hassouna M. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol, 1998, 159: 1476
7[6]Schmidt RA, Jonas U, Oleson KA et al. Sacral nerve stimulation for treatment of refactory urinary urge incontinence. J Urol, 1999,162: 352
8[7]Das AK, White MD, Longhurst PA. Scral nerve stimulation for the management of voiding dysfunction. Rev Urol, 2000,2: 43
9Schurch B, Stoehrer M, Kramer G, et al. Botulinum -A toxin for treating detrusor hyperreflexia in spinal cord injured patients:a new alternative to anticholinergic drugs? Preliminary results. J Urol, 2000,164:692-697.
10Abrams P,Larsson G, Chapple C, et al. Factors involved in the success of antimuscarintc treatment. BJU Int, 1999,83 (suppl) :42-47.
6许桂晓,彭康强,张卫东,等.增强3D SPACE STIR序列在显示腰骶神经根中的应用价值.中华临床医师杂志(电子版),2013,7(6):2497-2500.
7Possover M.The laparoscopic implantation of neuroprothesis to the sacral plexus for therapy of neurogenic bladder dysfunctions after failure of percutaneous sacral nerve stimulation.Neuromodulation,2010,13(2):141-144.
8Thawait SK,Wang K,Subhawong TK,et al.Peripheral nerve surgery:the role of high-resolution MR neurography.AJNR Am J Neuroradiol,2012,33(2):203-210.
9Possover M,Baekelandt J,Flaskamp C,et al.Laparoscopic neurolysis of the sacral plexus and the sciatic nerve for extensive endometriosis of the pelvic wall.Minim Invasive Neurosurg,2007,50(1):33-36.
10Moriya S,Miki Y,Matsuno Y,et al.Three-dimensional double-echo steady-state(3D-DESS)magnetic resonance imaging of the knee:establishment of flip angles for evaluation of cartilage at 1.5 T and 3.0T.Acta Radiol,2012,53(7):790-794.
